- Home
- BIOA vs BCTXW Comparison
BIOA vs BCTXW Comparison
Compare BIOA & BCTXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIOA
- BCTXW
- Stock Information
- Founded
- BIOA 2015
- BCTXW N/A
- Country
- BIOA United States
- BCTXW Canada
- Employees
- BIOA N/A
- BCTXW 12
- Industry
- BIOA Biotechnology: Pharmaceutical Preparations
- BCTXW Biotechnology: Pharmaceutical Preparations
- Sector
- BIOA Health Care
- BCTXW Health Care
- Exchange
- BIOA Nasdaq
- BCTXW Nasdaq
- Market Cap
- BIOA N/A
- BCTXW N/A
- IPO Year
- BIOA 2024
- BCTXW N/A
- Fundamental
- Price
- BIOA $21.89
- BCTXW $0.31
- Analyst Decision
- BIOA
- BCTXW
- Analyst Count
- BIOA 0
- BCTXW 0
- Target Price
- BIOA N/A
- BCTXW N/A
- AVG Volume (30 Days)
- BIOA 1.2M
- BCTXW N/A
- Earning Date
- BIOA 11-15-2024
- BCTXW N/A
- Dividend Yield
- BIOA N/A
- BCTXW N/A
- EPS Growth
- BIOA N/A
- BCTXW N/A
- EPS
- BIOA N/A
- BCTXW N/A
- Revenue
- BIOA N/A
- BCTXW N/A
- Revenue This Year
- BIOA N/A
- BCTXW N/A
- Revenue Next Year
- BIOA N/A
- BCTXW N/A
- P/E Ratio
- BIOA N/A
- BCTXW N/A
- Revenue Growth
- BIOA N/A
- BCTXW N/A
- 52 Week Low
- BIOA $18.30
- BCTXW N/A
- 52 Week High
- BIOA $24.00
- BCTXW N/A
- Technical
- Relative Strength Index (RSI)
- BIOA N/A
- BCTXW N/A
- Support Level
- BIOA N/A
- BCTXW N/A
- Resistance Level
- BIOA N/A
- BCTXW N/A
- Average True Range (ATR)
- BIOA 0.00
- BCTXW 0.00
- MACD
- BIOA 0.00
- BCTXW 0.00
- Stochastic Oscillator
- BIOA 0.00
- BCTXW 0.00
About BCTXW BriaCell Therapeutics Corp. Warrant
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.